PHILADELPHIA (September 1, 2021) – Fox Chase Cancer Center is pleased to announce the hiring of Melissa McShane, MD, who will join the Breast Cancer Medical Oncology Program as an attending physician.
McShane will begin work following completion of the Fox Chase-Temple University Hematology/Oncology Fellowship Program. In 2020, she was named chief fellow of the program.
Prior to joining the center’s team, she worked as an oncology hospitalist in the Bone Marrow Transplant Unit of the University of Virginia, where she also completed her medical residency in internal medicine.
McShane graduated cum laude from the Sidney Kimmel Medical College at Thomas Jefferson University in 2014. While attending the university, she was inducted into multiple honors societies and received the Arnold R. Weitz, MD, Memorial Award in Hematology and the Foerderer Award for International Study.
As an undergraduate, she attended the University of Pittsburgh and graduated summa cum laude with a bachelor of science in biology degree.
McShane is a member of the American Medical Association, the American College of Physicians, the American Society of Clinical Oncology, and the American Society of Hematology.
McShane’s ongoing studies center around her specialization in breast cancer. Her research focus includes a retrospective analysis of the effectiveness of alternating mammogram and magnetic resonance imaging every six months for screening women at high risk for breast cancer, treatment patterns of older adults with metastatic breast cancer, and a case report on the response to checkpoint inhibition in a patient with metastatic HER2-positive breast cancer.
She will begin her position at Fox Chase on September 1, 2021.